Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023

BUY
$214.27 - $253.37 $85,708 - $101,348
400 New
400 $88,000
Q2 2022

Jul 22, 2022

BUY
$230.71 - $256.74 $20,533 - $22,849
89 Added 6.27%
1,509 $367,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $282,409 - $323,192
1,420 New
1,420 $319,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Financial Connections Group, Inc. Portfolio

Follow Financial Connections Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Connections Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Connections Group, Inc. with notifications on news.